Shanghai Medicilon Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 259.51 million compared to CNY 451.4 million a year ago. Revenue was CNY 259.51 million compared to CNY 451.4 million a year ago.

Net loss was CNY 37.56 million compared to net income of CNY 101.57 million a year ago. Basic loss per share from continuing operations was CNY 0.28 compared to basic earnings per share from continuing operations of CNY 0.84 a year ago. Diluted loss per share from continuing operations was CNY 0.28 compared to diluted earnings per share from continuing operations of CNY 0.84 a year ago.